Monday 24 July 2017

Diagnosis of Intermediate-Risk Polycythemia Vera - Targeted Oncology


Diagnosis of Intermediate-Risk Polycythemia Vera
Targeted Oncology
They are really aimed at trying to prevent thrombosis or bleeding, and they include, certainly, trying to manage his cardiovascular risk factors. So, individuals are managed on a basis of phlebotomy to control the hematocrit. Ideally, in 2017, we know ...

and more »


from phlebotomy - Google News http://bit.ly/2tvaVW1

No comments:

Post a Comment